تجاوز إلى المحتوى الرئيسي
drug protocol number
CNTO1959CRD3005
drug sponsor
Janssen Research & Development LLC
drug study
Guselkumab
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Specialist Hospital (Dammam), King Saud Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah)
drug status
Ongoing
drug phase